Award
National Institute of Allergy and Infectious Diseases 2R01AI162307-05
Investigation of Synthetic DNA-based Viral Particles for Spatially Controlled Antigen Presentation
Recipient
Massachusetts Institute of Technology, Cambridge, MA, United States
Award Amount
$844,182.00
Ceiling
$844,182.00
Awarded
February 09, 2026
Identifier
2R01AI162307-05
Research project investigating DNA-based virus-like particles to optimize HIV and influenza vaccines by focusing on antigen organization, VLP size and geometry, glycosylation, and immune targeting to generate broadly neutralizing antibodies.
Description
This is a research project funded by NIH/NIAID focusing on vaccine development for HIV and influenza using DNA-based virus-like particles. The project aims to optimize vaccine design parameters to elicit broadly neutralizing antibodies.